Reviewing P3 Health Partners (PIII) & Its Competitors

P3 Health Partners (NASDAQ:PIII) is one of 32 publicly-traded companies in the “Health services” industry, but how does it compare to its rivals? We will compare P3 Health Partners to related companies based on the strength of its earnings, risk, valuation, institutional ownership, analyst recommendations, profitability and dividends.

Earnings and Valuation

This table compares P3 Health Partners and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
P3 Health Partners	$1.14 billion	-$270.13 million	0.00
P3 Health Partners Competitors	$1.69 billion	-$102.87 million	22.81

P3 Health Partners’ rivals have higher revenue and earnings than P3 Health Partners. P3 Health Partners is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares P3 Health Partners and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-10.92%	-2,471.27%	33.63%
P3 Health Partners Competitors	-163.10%	-230.92%	-18.53%

Analyst Ratings

This is a summary of current ratings and price targets for P3 Health Partners and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	0	1	1	0	2.50
P3 Health Partners Competitors	10	158	310	0	2.63

P3 Health Partners presently has a consensus target price of $5.00, indicating a potential upside of 135.85%. As a group, “Health services” companies have a potential upside of 109.03%. Given P3 Health Partners’ higher probable upside, research analysts clearly believe P3 Health Partners is more favorable than its rivals.

Risk and Volatility

P3 Health Partners has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Comparatively, P3 Health Partners’ rivals have a beta of 1.50, suggesting that their average stock price is 50% more volatile than the S&P 500.

Institutional & Insider Ownership

23.6% of P3 Health Partners shares are owned by institutional investors. Comparatively, 46.9% of shares of all “Health services” companies are owned by institutional investors. 17.1% of P3 Health Partners shares are owned by insiders. Comparatively, 22.9% of shares of all “Health services” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

P3 Health Partners rivals beat P3 Health Partners on 9 of the 12 factors compared.

P3 Health Partners Company Profile

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.